Real-life Security and Efficacy of DAA-based Therapy in HCV/HIV-Coinfected Patients
Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and tolerability of DAA-based regimens
in the clinical practice in HIV/HCV-coinfected patients.
Hypothesis: The efficacy and tolerability of DAA-based regimens in the clinical practice is
different to what is observed in clinical trials in HIV/HCV-coinfected patients.
Details
Lead Sponsor:
Valme University Hospital
Collaborators:
Complejo Hospitalario de Jaén Complejo Hospitalario Universitario de Huelva Fundación de Investigación Biomédica - Hospital Universitario de La Princesa Hospital Álvaro Cunqueiro Hospital La Línea Hospital Poniente Hospital Regional de Malaga Hospital Torrecárdenas Hospital Universitario Central de Asturias Hospital Universitario de Canarias Hospital Universitario de Gran Canaria Hospital Universitario Puerta del Mar Hospital Universitario Puerto Real Hospital Universitario Reina Sofia Hospital Universitario Reina Sofia de Cordoba Hospital Universitario Virgen de la Arrixaca Hospital Universitario Virgen de la Victoria Hospital Universitario Virgen Macarena